isoborneol has been researched along with Ischemic Stroke in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gao, Y; Li, H; Li, Z; Liang, C; Liu, Z; Peng, P; Qi, D; Yang, Z; Zhang, Q | 1 |
Chen, H; Chen, X; Dong, A; Gao, Z; Geng, D; Ji, Y; Li, S; Liu, B; Lu, Z; Meng, X; Mu, H; Wang, A; Wang, Y; Xu, A; Xu, J; Yalkun, G; Zhao, X; Zheng, H; Zhu, R | 1 |
1 trial(s) available for isoborneol and Ischemic Stroke
Article | Year |
---|---|
Edaravone Dexborneol Versus Edaravone Alone for the Treatment of Acute Ischemic Stroke: A Phase III, Randomized, Double-Blind, Comparative Trial.
Topics: Adult; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents; Antioxidants; Camphanes; Double-Blind Method; Edaravone; Female; Humans; Ischemic Stroke; Male; Middle Aged; Neuroprotective Agents; Treatment Outcome | 2021 |
1 other study(ies) available for isoborneol and Ischemic Stroke
Article | Year |
---|---|
Herb-drug interaction of Xingnaojing injection and Edaravone via pharmacokinetics, mixed inhibition of UGTs, and molecular docking.
Topics: Animals; Chromatography, Liquid; Edaravone; Glucuronosyltransferase; Herb-Drug Interactions; Ischemic Stroke; Molecular Docking Simulation; Rats; Tandem Mass Spectrometry | 2023 |